Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will shorten lead times and reduce costs—with the aim to give more patients access to advanced, potentially curative treatments.
Continue Reading this article here
